Robert Soliva

He took a BSc in Molecular Biology and Biochemistry at the University of Barcelona (UB), finishing studies in the UK. Later, he got a PhD in computational chemistry with Professor Modesto Orozco (UB- IRB-Institute of Research in Biomedicine). He worked at the Drug Discovery unit of Laboratorios Uriach/Palau Pharma for 11 years, during which he actively contributed to the development of several clinical candidates. Afterwards, he worked during 6 years at the IP law firm ZBM Patents&Trademarks, successfully passing the first exam of the EPO. In 2016 he co-founded and launched the company Nostrum Biodiscovery, the first spin off of the BSC (Barcelona Supercomputing Center) and IRB . At Nostrum he acted first as CSO and then as CSO/CEO, taking the company from 0 to 14 employees. He later took on the role of Head of Drug Discovery for Oryzon Genomics. He is currently Associate Director at the R+D Data Science Dpt. of Almirall.